(1)
BASHINI, M.; SHAH, S.; DESAI, C. AN EVALUATION OF ADVERSE DRUG REACTIONS WITH REMDESIVIR IN PATIENTS OF COVID-19. Asian J Pharm Clin Res 2022, 15, 88-91.